Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,961 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00001689 | A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia | completed | Phase 1 | 90 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001693 | Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 |
| clinicaltrials |
| NCT00001696 | A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001748 | HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies | completed | Phase 1 | 35 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001835 | Oxaliplatin in Cancer Patients With Impaired Kidney Function | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001944 | Vinorelbine and XR9576 to Treat Cancer | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00004988 | Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00005785 | Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer | completed | Phase 1 | 30 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00006155 | SU5416 and Carboplatin to Treat Ovarian Cancer | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00026871 | Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00055380 | Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients | completed | Phase 1 | 120 | National Institute of Dental and Craniofacial Research (NIDCR)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00078494 | Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer | completed | Phase 1 | 99 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00393965 | Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases | completed | Phase 1 | 18 | Myrexis Inc.INDUSTRY | 1 | Feb 13, 2008 | clinicaltrials |
| NCT00394446 | Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors | completed | Phase 1 | 48 | Myrexis Inc.INDUSTRY | 1 | Feb 13, 2008 | clinicaltrials |
| NCT00064610 | Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer | completed | Phase 1 / Phase 2 | 102 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00129207 | Ketoconazole Administration: How it is Affected by the Body and Broken Down and How it Acts on the Body When Used With Velcade | completed | Phase 1 | — | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00274248 | MLN518 in Combination With Standard Induction Chemo. for Treatment of Patients With Newly Diagnosed Acute Myelogenous Leukemia | completed | Phase 1 | — | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00001535 | Twins Study of Gene Therapy for HIV Infection | completed | Phase 1 | 48 | National Human Genome Research Institute (NHGRI)NIH | 1 | Feb 8, 2008 | clinicaltrials |
| NCT00098917 | Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | terminated | Phase 1 | 15 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 28, 2008 | clinicaltrials |
| NCT00090389 | Acupuncture for Women's Health Conditions | completed | Phase 1 | 50 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00259818 | Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors | completed | Phase 1 | 30 | Erimos PharmaceuticalsINDUSTRY | 1 | Jan 24, 2008 | clinicaltrials |
| NCT00104468 | Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML) | terminated | Phase 1 / Phase 2 | 50 | SGX Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 17, 2008 | clinicaltrials |
| NCT00056173 | Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 43 | Aptose Biosciences Inc.INDUSTRY | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00393809 | Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer | completed | Phase 1 / Phase 2 | 18 | Hebrew University of JerusalemOTHER | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00197925 | Dendritic Cell Based Therapy of Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 40 | Herlev HospitalOTHER | 1 | Jan 3, 2008 | clinicaltrials |
| NCT00077493 | BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma | suspended | Phase 1 | 95 | MedImmune LLCINDUSTRY | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00165373 | rhEndostatin Protein Involving Pediatric Patients With Cancer | terminated | Phase 1 | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00417677 | A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma | terminated | Phase 1 / Phase 2 | 124 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00116441 | Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma | completed | Phase 1 / Phase 2 | 22 | Cell GenesysINDUSTRY | 1 | Dec 24, 2007 | clinicaltrials |
| NCT00140348 | Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine | completed | Phase 1 / Phase 2 | 80 | Cell GenesysINDUSTRY | 1 | Dec 24, 2007 | clinicaltrials |
| NCT00580450 | Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies | unknown | Phase 1 / Phase 2 | 9 | University Of PerugiaOTHER | 1 | Dec 24, 2007 | clinicaltrials |
| NCT00086216 | Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma | completed | Phase 1 / Phase 2 | 30 | Callisto PharmaceuticalsINDUSTRY | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00121095 | Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer | unknown | Phase 1 / Phase 2 | 69 | Cytogen CorporationINDUSTRY | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00271063 | Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia | unknown | Phase 1 / Phase 2 | 34 | Callisto PharmaceuticalsINDUSTRY | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00121745 | Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer | terminated | Phase 1 | 12 | Epeius BiotechnologiesINDUSTRY | 1 | Dec 20, 2007 | clinicaltrials |
| NCT00252798 | ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer | completed | Phase 1 | 44 | AstraZenecaINDUSTRY | 1 | Dec 19, 2007 | clinicaltrials |
| NCT00034138 | A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma | terminated | Phase 1 / Phase 2 | 24 | Unither PharmaceuticalsINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00239304 | Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer | completed | Phase 1 / Phase 2 | 40 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00257881 | Study Evaluating Intravenous CMD-193 in Subjects With Advanced Malignant Solid Tumors | terminated | Phase 1 | 46 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 10, 2007 | clinicaltrials |
| NCT00122876 | Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 25 | Light Sciences OncologyINDUSTRY | 3 | Dec 7, 2007 | clinicaltrials |
| NCT00427544 | Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential | completed | Phase 1 | — | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 5, 2007 | clinicaltrials |
| NCT00283829 | Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | 30 | University of WashingtonOTHER | 1 | Nov 29, 2007 | clinicaltrials |
| NCT00031031 | Kanglaite Injection Phase I Study | completed | Phase 1 | 16 | KangLaiTe USAINDUSTRY | 1 | Nov 27, 2007 | clinicaltrials |
| NCT00145743 | Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer | completed | Phase 1 / Phase 2 | 200 | Tumor Center RegensburgOTHER | 1 | Nov 27, 2007 | clinicaltrials |
| NCT00562471 | Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation | completed | Phase 1 / Phase 2 | 76 | Angiotech PharmaceuticalsINDUSTRY | 3 | Nov 22, 2007 | clinicaltrials |
| NCT00215709 | Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer | completed | Phase 1 | 17 | Geriatric Oncology ConsortiumOTHER | 1 | Nov 19, 2007 | clinicaltrials |
| NCT00559026 | Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients(DTIC-melvacc) | completed | Phase 1 | 10 | Istituto Superiore di SanitàOTHER | 1 | Nov 16, 2007 | clinicaltrials |
| NCT00216437 | Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma | terminated | Phase 1 | 30 | James A. Haley Veterans Administration HospitalFED | 1 | Nov 12, 2007 | clinicaltrials |
| NCT00555516 | A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy | unknown | Phase 1 / Phase 2 | 60 | Tri-Service General Hospital (TSGH)OTHER | 1 | Nov 8, 2007 | clinicaltrials |
| NCT00057447 | Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients | terminated | Phase 1 / Phase 2 | 24 | InterMuneINDUSTRY | 1 | Nov 1, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Mar 4, 2008source: clinicaltrials